Skip to content

In Vivo Evaluation of Visible Light Protection in Tinted Sunscreen: A Randomized Double-Blinded Controlled Trial

In Vivo Evaluation of Visible Light Protection in Tinted Sunscreen: A Randomized Double-Blinded Controlled Trial

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
TCTR
Registry ID
TCTR20250917005
Enrollment
10
Registered
2025-09-17
Start date
2024-08-07
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy volunteers tinted sunscreen, visible light protection, immediate pigment darkening, Individual Typology Angle, iron oxide

Interventions

Four investigational zones measuring 5x7 cm were marked on the mid-back region of each participant: one positive control zone (irradiated without product application), and three zones pre-treated with
Experimental Drug
Tinted sunscreen and broad-spectrum sunscreen

Sponsors

Faculty of Medicine Siriraj Hospital, Mahidol University
Lead Sponsor
Dermatological Society of Thailand
Collaborator

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Healthy volunteers aged 18 years or older 2. Have a tan, brown, or dark skin tone, as assessed using the ITA (Individual Typology Angle) value of 10 to -40 measured with a colorimeter on the lower back area (the test site). 3. Can avoid sun exposure to the back area during the study period. 4. Can lie on their stomach continuously for at least 1 hour without any respiratory problems. 5. Can communicate effectively in Thai.

Exclusion criteria

Exclusion criteria: 1. Individuals with a history of sunbathing or excessive sun exposure to the back within the last month. 2. Individuals with a history of using photosensitizing agents, immunosuppressants, or anti-inflammatory medications within the last month. 3. Individuals with a history of laser treatment or artificial sunlight exposure to the back within the last 6 months. 4. Individuals with plans for any treatment or procedure on the back during the study period that may affect the results. 5. Individuals with photosensitivity, photosensitive rash, skin cancer, or skin conditions exacerbated by sunlight, such as systemic lupus erythematosus. 6. Individuals with open wounds, skin infections, or skin rashes on the back. 7. Individuals who are pregnant, breastfeeding, or within 3 months postpartum (as determined by menstrual history, contraception history, and physical examination by a physician). 8. Individuals with a history of allergy to sunscreen.

Design outcomes

Primary

MeasureTime frame
Visible light protection 15 minutes, 1 day, and 7 days post-irradiation colorimeter

Secondary

MeasureTime frame
Investigators Global Assessment 15 minutes, 1 day, and 7 days post-irradiation Two independent physicians grading,Pigmentation assessments 15 minutes, 1 day, and 7 days post-irradiation colorimeter

Countries

Thailand

Contacts

Public ContactYanisorn Nanchaipruek

Faculty of Medicine Siriraj Hospital, Mahidol University

yanisorn.nan@gmail.com024194333

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026